logo
1-800-590-1161ContactEarn free travel
logo1-800-590-1161

Entry Requirements

Enter the name of the tour you’re reserved on, or have on your wish list, to view the most up to date entry requirements.

Choose a different tour

Alaska’s National Parks: Denali & the Kenai Fjords

Choose departure year
    EF Go Ahead Tours currently requires that all tour participants be fully vaccinated against COVID-19 and must have proof of negative results for a COVID-19 test
    taken within 72-hours before departure. These requirements are in addition to any destination requirements listed below due to US Department of State and CDC guidance, the wellbeing of the group, and/or operational feasibility.

    The United States to The United States

    Please note: Local requirements may be listed for destinations not visited on your tour itinerary. Cross-reference your itinerary to confirm which guidelines apply to you.

    General information

    Masks are mandatory on public transportation

    Travelers must wear masks on public transportation in the United States. Some states still require the use of masks in public places, please verify the regional requirements before traveling.

    Centers for Disease Control and Prevention

    Documents needed

    Mandatory proof of vaccinationNEEDED BEFORE ARRIVAL

    Travelers are considered fully vaccinated against COVID-19 if 2 weeks have passed since their second dose in a 2-dose series, such as the Pfizer-BioNTech or Moderna vaccines, or 2 weeks after a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine. The US government currently accepts vaccines approved or authorized for emergency use by the U.S. FDA and the WHO. Vaccines accepted are Pfizer-BioNTech (e.g., COMIRNATY, Tozinameran), AstraZeneca-Oxford (e.g., Covishield, Vaxzevria), Janssen (Johnson & Johnson), Moderna, Sinopharm BIBP, Covaxin and Sinovac-CoronaVac. Travelers unable to present a valid certificate may be required to comply with rules for unvaccinated travelers.

    Any combination of 2 doses of an FDA approved/authorized or WHO emergency use listed COVID-19 2-dose series are accepted. The second dose in a 2-dose heterologous series must have been received no earlier than 17 days (21 days with a 4 day grace period) after the first dose. For more information about accepted proof of vaccination, please check the source.